Archive for the AF267B category

Alzheimer’s Research Discovers Disease Blocker

By Mark Walters

A break-through in Alzheimer’s research has found a compound that blocks the progression of Alzheimer’s disease.

The discovery occured at the University of California at Irvine. An Alzheimer’s research group there has announced the new Alzheimer’s drug treatment that they have named AF267B.

In tests on mice AF267B reversed the symptoms of memory loss and problems with learning that are associated with Alzheimer’s disease. The drug is not a cure for the disease, but it is important because the research has shown that it will block the progress of Alzheimer’s. That means that once diagnosed it appears that the loss of brain function can be controlled.

More →